| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | complement component C3b binding | 2.90e-08 | 12 | 57 | 4 | GO:0001851 | |
| GeneOntologyMolecularFunction | complement binding | 3.01e-08 | 32 | 57 | 5 | GO:0001848 | |
| GeneOntologyMolecularFunction | opsonin binding | 7.22e-07 | 25 | 57 | 4 | GO:0001846 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 4.17e-04 | 51 | 57 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | voltage-gated chloride channel activity | 4.33e-04 | 11 | 57 | 2 | GO:0005247 | |
| GeneOntologyMolecularFunction | lipase activity | 6.49e-04 | 138 | 57 | 4 | GO:0016298 | |
| GeneOntologyMolecularFunction | carboxylic ester hydrolase activity | 1.05e-03 | 157 | 57 | 4 | GO:0052689 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 1.06e-03 | 17 | 57 | 2 | GO:0008308 | |
| GeneOntologyMolecularFunction | immunoglobulin receptor binding | 1.62e-03 | 21 | 57 | 2 | GO:0034987 | |
| GeneOntologyBiologicalProcess | complement activation | 3.89e-08 | 70 | 57 | 6 | GO:0006956 | |
| GeneOntologyBiologicalProcess | cytolysis by host of symbiont cells | 2.37e-06 | 10 | 57 | 3 | GO:0051838 | |
| GeneOntologyBiologicalProcess | humoral immune response | 2.69e-06 | 321 | 57 | 8 | GO:0006959 | |
| GeneOntologyBiologicalProcess | complement activation, alternative pathway | 1.88e-05 | 19 | 57 | 3 | GO:0006957 | |
| GeneOntologyBiologicalProcess | regulation of complement activation | 5.58e-05 | 27 | 57 | 3 | GO:0030449 | |
| GeneOntologyBiologicalProcess | killing by host of symbiont cells | 1.58e-04 | 38 | 57 | 3 | GO:0051873 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation, classical pathway | 2.08e-04 | 8 | 57 | 2 | GO:0045959 | |
| GeneOntologyCellularComponent | IgM immunoglobulin complex, circulating | 2.17e-04 | 8 | 59 | 2 | GO:0071754 | |
| GeneOntologyCellularComponent | pentameric IgM immunoglobulin complex | 2.17e-04 | 8 | 59 | 2 | GO:0071756 | |
| GeneOntologyCellularComponent | monomeric IgA immunoglobulin complex | 2.78e-04 | 9 | 59 | 2 | GO:0071748 | |
| GeneOntologyCellularComponent | polymeric IgA immunoglobulin complex | 3.47e-04 | 10 | 59 | 2 | GO:0071749 | |
| GeneOntologyCellularComponent | IgA immunoglobulin complex, circulating | 3.47e-04 | 10 | 59 | 2 | GO:0071746 | |
| GeneOntologyCellularComponent | secretory IgA immunoglobulin complex | 3.47e-04 | 10 | 59 | 2 | GO:0071751 | |
| GeneOntologyCellularComponent | blood microparticle | 7.33e-04 | 144 | 59 | 4 | GO:0072562 | |
| GeneOntologyCellularComponent | IgA immunoglobulin complex | 8.03e-04 | 15 | 59 | 2 | GO:0071745 | |
| GeneOntologyCellularComponent | IgM immunoglobulin complex | 8.03e-04 | 15 | 59 | 2 | GO:0071753 | |
| GeneOntologyCellularComponent | immunoglobulin complex, circulating | 1.04e-03 | 17 | 59 | 2 | GO:0042571 | |
| GeneOntologyCellularComponent | lysosomal lumen | 2.69e-03 | 98 | 59 | 3 | GO:0043202 | |
| GeneOntologyCellularComponent | endolysosome | 3.24e-03 | 30 | 59 | 2 | GO:0036019 | |
| Domain | Sushi | 9.03e-09 | 52 | 55 | 6 | PF00084 | |
| Domain | CCP | 1.14e-08 | 54 | 55 | 6 | SM00032 | |
| Domain | SUSHI | 1.43e-08 | 56 | 55 | 6 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 1.59e-08 | 57 | 55 | 6 | IPR000436 | |
| Domain | Inhibitor_I29 | 1.77e-04 | 7 | 55 | 2 | PF08246 | |
| Domain | Prot_inhib_I29 | 1.77e-04 | 7 | 55 | 2 | IPR013201 | |
| Domain | Inhibitor_I29 | 1.77e-04 | 7 | 55 | 2 | SM00848 | |
| Domain | Pept_asp_AS | 3.77e-04 | 10 | 55 | 2 | IPR025661 | |
| Domain | Lipase_LIPH | 3.77e-04 | 10 | 55 | 2 | IPR016272 | |
| Domain | Lipase | 3.77e-04 | 10 | 55 | 2 | PF00151 | |
| Domain | Lipase_N | 3.77e-04 | 10 | 55 | 2 | IPR033906 | |
| Domain | Lipase/vitellogenin | 3.77e-04 | 10 | 55 | 2 | IPR013818 | |
| Domain | TAG_lipase | 3.77e-04 | 10 | 55 | 2 | IPR000734 | |
| Domain | Pept_his_AS | 4.60e-04 | 11 | 55 | 2 | IPR025660 | |
| Domain | Pept_C1 | 6.50e-04 | 13 | 55 | 2 | SM00645 | |
| Domain | Peptidase_C1A_C | 6.50e-04 | 13 | 55 | 2 | IPR000668 | |
| Domain | Peptidase_C1 | 6.50e-04 | 13 | 55 | 2 | PF00112 | |
| Domain | Peptidase_C1A | 6.50e-04 | 13 | 55 | 2 | IPR013128 | |
| Domain | LIPASE_SER | 2.64e-03 | 26 | 55 | 2 | PS00120 | |
| Domain | THIOL_PROTEASE_CYS | 2.64e-03 | 26 | 55 | 2 | PS00139 | |
| Domain | THIOL_PROTEASE_ASN | 2.85e-03 | 27 | 55 | 2 | PS00640 | |
| Domain | THIOL_PROTEASE_HIS | 2.85e-03 | 27 | 55 | 2 | PS00639 | |
| Domain | Pept_cys_AS | 3.06e-03 | 28 | 55 | 2 | IPR000169 | |
| Domain | - | 5.20e-03 | 119 | 55 | 3 | 3.40.50.1820 | |
| Domain | AB_hydrolase | 5.20e-03 | 119 | 55 | 3 | IPR029058 | |
| Domain | - | 6.18e-03 | 40 | 55 | 2 | 4.10.1000.10 | |
| Domain | - | 6.80e-03 | 42 | 55 | 2 | 3.20.20.70 | |
| Domain | Aldolase_TIM | 7.44e-03 | 44 | 55 | 2 | IPR013785 | |
| Domain | ZnF_C3H1 | 8.81e-03 | 48 | 55 | 2 | SM00356 | |
| Domain | zf-CCCH | 9.16e-03 | 49 | 55 | 2 | PF00642 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_CFHR | 1.23e-09 | 6 | 44 | 4 | M47880 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 2.13e-09 | 115 | 44 | 8 | M19752 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | CFHR1 CFHR2 TARM1 ANO6 ITLN1 IGKV3D-20 C4BPA ALAD CFHR5 CR2 MAP2K1 CTSK CTSV IGKV3-20 CFHR4 | 8.06e-07 | 1128 | 44 | 15 | M1036 |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 1.33e-04 | 84 | 44 | 4 | MM14653 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 2.23e-04 | 96 | 44 | 4 | M39581 | |
| Pathway | REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_KERATINOCYTES | 2.63e-04 | 8 | 44 | 2 | M27796 | |
| Pubmed | 1.36e-12 | 9 | 58 | 5 | 20059470 | ||
| Pubmed | Factor H-related proteins determine complement-activating surfaces. | 3.48e-11 | 5 | 58 | 4 | 25979655 | |
| Pubmed | Dimerization of complement factor H-related proteins modulates complement activation in vivo. | 1.04e-10 | 6 | 58 | 4 | 23487775 | |
| Pubmed | 1.04e-10 | 6 | 58 | 4 | 27196323 | ||
| Pubmed | 1.04e-10 | 6 | 58 | 4 | 17438673 | ||
| Pubmed | Risk of non-Hodgkin lymphoma in association with germline variation in complement genes. | 1.78e-09 | 31 | 58 | 5 | 19344414 | |
| Pubmed | C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation. | 4.40e-09 | 3 | 58 | 3 | 23728178 | |
| Pubmed | 4.39e-08 | 5 | 58 | 3 | 9799332 | ||
| Pubmed | Identification and sequence analysis of four complement factor H-related transcripts in mouse liver. | 4.39e-08 | 5 | 58 | 3 | 1689298 | |
| Pubmed | A radiation hybrid map of complement factor H and factor H-related genes. | 4.39e-08 | 5 | 58 | 3 | 10380701 | |
| Pubmed | 8.77e-08 | 6 | 58 | 3 | 18541031 | ||
| Pubmed | Genetic organization of complement receptor-related genes in the mouse. | 2.45e-07 | 8 | 58 | 3 | 2564419 | |
| Pubmed | FHR-1 Binds to C-Reactive Protein and Enhances Rather than Inhibits Complement Activation. | 3.67e-07 | 9 | 58 | 3 | 28533443 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 32636836 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 28673452 | ||
| Pubmed | The embryonically active gene, unkempt, of Drosophila encodes a Cys3His finger protein. | 2.73e-06 | 2 | 58 | 2 | 1339381 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 34260947 | ||
| Pubmed | Molecular cloning of a human serum protein structurally related to complement factor H. | 2.73e-06 | 2 | 58 | 2 | 1711047 | |
| Pubmed | A novel CFHR1-CFHR5 hybrid leads to a familial dominant C3 glomerulopathy. | 2.73e-06 | 2 | 58 | 2 | 28729035 | |
| Pubmed | Follicular Dendritic Cells Retain Infectious HIV in Cycling Endosomes. | 2.73e-06 | 2 | 58 | 2 | 26623655 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 22562303 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 33651882 | ||
| Pubmed | Complement factor H-related hybrid protein deregulates complement in dense deposit disease. | 2.73e-06 | 2 | 58 | 2 | 24334459 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 35392081 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 24719048 | ||
| Pubmed | Genome-wide association study identifies susceptibility loci for IgA nephropathy. | 4.18e-06 | 19 | 58 | 3 | 21399633 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 19828624 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 5027703 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 22126332 | ||
| Pubmed | Cathepsin K activity-dependent regulation of osteoclast actin ring formation and bone resorption. | 8.19e-06 | 3 | 58 | 2 | 19028686 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 31273197 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 30931961 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 21637784 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 23871919 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 17889653 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 24333077 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 32007579 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 36793547 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 16939398 | ||
| Pubmed | Cathepsin protease activity modulates amyloid load in extracerebral amyloidosis. | 1.64e-05 | 4 | 58 | 2 | 17068745 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 21251246 | ||
| Pubmed | 2.11e-05 | 32 | 58 | 3 | 23750785 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 20212043 | ||
| Pubmed | Complement factor H and related proteins: an expanding family of complement-regulatory proteins? | 2.72e-05 | 5 | 58 | 2 | 8172644 | |
| Pubmed | Cathepsin V, but not cathepsins L, B and K, may release angiostatin-like fragments from plasminogen. | 2.72e-05 | 5 | 58 | 2 | 18163891 | |
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 33786919 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 12782676 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 20962256 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 98179 | ||
| Pubmed | Mouse cathepsin M, a placenta-specific lysosomal cysteine protease related to cathepsins L and P. | 4.08e-05 | 6 | 58 | 2 | 10760593 | |
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 99744 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 3351922 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 4691517 | ||
| Pubmed | 5.71e-05 | 7 | 58 | 2 | 9603450 | ||
| Pubmed | 5.71e-05 | 7 | 58 | 2 | 19861685 | ||
| Pubmed | 7.60e-05 | 8 | 58 | 2 | 20301598 | ||
| Pubmed | 7.60e-05 | 8 | 58 | 2 | 28835281 | ||
| Pubmed | Asparagine endopeptidase controls anti-influenza virus immune responses through TLR7 activation. | 7.60e-05 | 8 | 58 | 2 | 22916010 | |
| Pubmed | STK25 and MST3 Have Overlapping Roles to Regulate Rho GTPases during Cortical Development. | 9.77e-05 | 9 | 58 | 2 | 34518307 | |
| Pubmed | 9.78e-05 | 143 | 58 | 4 | 22516433 | ||
| Pubmed | 1.22e-04 | 10 | 58 | 2 | 3416634 | ||
| Pubmed | 1.22e-04 | 10 | 58 | 2 | 20949042 | ||
| Pubmed | Enhanced analysis of the mouse plasma proteome using cysteine-containing tryptic glycopeptides. | 1.34e-04 | 59 | 58 | 3 | 17330941 | |
| Pubmed | 1.49e-04 | 11 | 58 | 2 | 20301541 | ||
| Pubmed | Ischemic stroke is associated with the ABO locus: the EuroCLOT study. | 2.46e-04 | 14 | 58 | 2 | 23381943 | |
| Pubmed | 2.46e-04 | 14 | 58 | 2 | 23577725 | ||
| Pubmed | The zinc finger/RING domain protein Unkempt regulates cognitive flexibility. | 2.83e-04 | 15 | 58 | 2 | 34381067 | |
| Pubmed | Genetic influences on the end-stage effector phase of arthritis. | 3.23e-04 | 16 | 58 | 2 | 11489951 | |
| Pubmed | 3.66e-04 | 17 | 58 | 2 | 33634103 | ||
| Pubmed | 4.11e-04 | 18 | 58 | 2 | 9090377 | ||
| Pubmed | Identification of transcripts with enriched expression in the developing and adult pancreas. | 5.97e-04 | 624 | 58 | 6 | 18554416 | |
| Pubmed | Genetic contributions of nonautoimmune SWR mice toward lupus nephritis. | 7.37e-04 | 24 | 58 | 2 | 11739537 | |
| Pubmed | Comparative analysis of 1196 orthologous mouse and human full-length mRNA and protein sequences. | 8.00e-04 | 25 | 58 | 2 | 8889551 | |
| Pubmed | 9.34e-04 | 27 | 58 | 2 | 2574151 | ||
| Pubmed | 1.31e-03 | 32 | 58 | 2 | 18842294 | ||
| Pubmed | 1.66e-03 | 36 | 58 | 2 | 7558020 | ||
| Cytoband | 1q32 | 4.99e-07 | 49 | 59 | 4 | 1q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q31 | 2.79e-06 | 75 | 59 | 4 | chr1q31 | |
| Cytoband | 1q31.3 | 1.93e-04 | 16 | 59 | 2 | 1q31.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q32 | 1.91e-03 | 50 | 59 | 2 | chr9q32 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 4.17e-09 | 57 | 43 | 6 | 1179 | |
| GeneFamily | Complement system|Sushi domain containing | 2.14e-08 | 36 | 43 | 5 | 492 | |
| GeneFamily | Cathepsins | 5.69e-04 | 15 | 43 | 2 | 470 | |
| GeneFamily | Zinc fingers CCCH-type | 3.13e-03 | 35 | 43 | 2 | 73 | |
| Coexpression | STK33_SKM_UP | 2.72e-06 | 279 | 58 | 7 | M2857 | |
| Coexpression | LEE_LIVER_CANCER_MYC_E2F1_DN | 1.24e-05 | 64 | 58 | 4 | M5636 | |
| Coexpression | NABA_MATRISOME | FAM20C OTOGL HYAL1 ITLN1 C4BPA C1QTNF7 PLXNB2 MUC2 CTSK CTSV | 6.59e-05 | 1008 | 58 | 10 | MM17056 |
| Coexpression | GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_DN | 7.20e-05 | 195 | 58 | 5 | M8132 | |
| Coexpression | GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN | 7.56e-05 | 197 | 58 | 5 | M8686 | |
| Coexpression | GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_UP | 8.12e-05 | 200 | 58 | 5 | M4574 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Bcl11b-Inhibitory_Gad1Gad2_Id2.Bcl11b_(Interneuron,_Neurogliaform2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.04e-06 | 68 | 59 | 4 | cfd75c373e10b3761666ccd445ba74755efeb95f | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Bcl11b|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.04e-06 | 68 | 59 | 4 | c25fb921dc83eecdc337353894829ae6b5192353 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Bcl11b-Inhibitory_Gad1Gad2_Id2.Bcl11b_(Interneuron,_Neurogliaform2)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.04e-06 | 68 | 59 | 4 | 712f5f4d3a1e0c0db1a340332876206b93bdac31 | |
| ToppCell | TCGA-Liver|World / Sample_Type by Project: Shred V9 | 3.45e-06 | 174 | 59 | 5 | 452932f08cf53e5949672a025d78cecb874aa4b0 | |
| ToppCell | TCGA-Colorectal-Recurrent_Tumor|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.55e-06 | 175 | 59 | 5 | 7f74961436f88c0e380819095e6104489914d765 | |
| ToppCell | TCGA-Colorectal-Recurrent_Tumor-Colorectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.55e-06 | 175 | 59 | 5 | bee8f31f036dfcf9fc6ed29156554771a9ee3c60 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.91e-06 | 187 | 59 | 5 | edb0ab0154542b1c0b3a2c216c4a60f0f06290b3 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.17e-06 | 189 | 59 | 5 | 7899af78b273d9c7f029d52f7e0cf6df4da41f5e | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.30e-06 | 190 | 59 | 5 | a34293601aefe5fb5c400c14091294b9ddaa195b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.32e-06 | 197 | 59 | 5 | 280804810041783f1b7704914b62ffefbb0d88f6 | |
| ToppCell | mLN-T_cell-Tfh|T_cell / Region, Cell class and subclass | 6.64e-06 | 199 | 59 | 5 | a234f14ff46a0dc2f916a80e1e7af7d793006050 | |
| ToppCell | Control-Myeloid-Dendritic_cells-pDC|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.10e-05 | 145 | 59 | 4 | bab85a72142b6257f7d424e5301f65b6dcdf745d | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-MAIT|GI_small-bowel / Manually curated celltypes from each tissue | 4.22e-05 | 146 | 59 | 4 | 1cb2e157222631e8915d89b255a843d16d7d99cc | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Control / Condition, Lineage and Cell class | 8.33e-05 | 174 | 59 | 4 | 4c64ff5666812fb4efa440ba4faeca51d916d68e | |
| ToppCell | B_cells-pDCs|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 8.71e-05 | 176 | 59 | 4 | ce757de9e09a225f3f96433f103f43619b0e0dda | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class | 8.90e-05 | 177 | 59 | 4 | 470f54fe2b21c7350ea471e02039461a3808f700 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.10e-05 | 178 | 59 | 4 | 107dae8b00c4257697a63700e72bb434cdb8406f | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma-monocytoid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.50e-05 | 180 | 59 | 4 | ba4c1fb55e8f1095bea6968417fefcf5f700926b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 9.70e-05 | 181 | 59 | 4 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.91e-05 | 182 | 59 | 4 | bb7de0c93d8f59f13c990e425139b9348ca8027e | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular-Chondrocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.91e-05 | 182 | 59 | 4 | 507f095af4dff60f2c2b64d750477154084c3595 | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.91e-05 | 182 | 59 | 4 | 88bd17c07bd8443a0ede4e9dc7bc9d1230b42211 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-CD5+_CCL22-_mature_B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.03e-04 | 184 | 59 | 4 | 18aa9c43b79d12c9e420dfd9822745c022be6789 | |
| ToppCell | facs-Thymus-Epithelium-24m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 185 | 59 | 4 | eaa54b76743628c89b4310be57b87fa92b75fd37 | |
| ToppCell | facs-Thymus-Epithelium-24m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 185 | 59 | 4 | f7f4c921d248c637351e2e882589b99ba7f04b66 | |
| ToppCell | facs-Thymus-Epithelium-24m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 185 | 59 | 4 | ff38a15af3dec36d9993f06623591872b5d1da9a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Macrophage|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.17e-04 | 190 | 59 | 4 | e1c02fe6fa43a36381cb9f02569fa9b1c5f5efdc | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.17e-04 | 190 | 59 | 4 | 4b9bac17eb7ceadada932f2d4a20a5f176088d53 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.17e-04 | 190 | 59 | 4 | 6de15ec88426fbf52acb0a8371f82cf03b6a6237 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-04 | 193 | 59 | 4 | 45205ad1ef12aabf33059a7ff922a3bb86994c2f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-04 | 193 | 59 | 4 | 1beca3d3b34082b7d9112fbd094bee8019921ca0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-04 | 193 | 59 | 4 | 2ebb950476767f330241b0077ced22e55e124359 | |
| ToppCell | distal-Hematologic-EREG+_Dendritic-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.32e-04 | 196 | 59 | 4 | c17bb7b3992bfec194bfa310f201a5c64b35868e | |
| ToppCell | Monocytes-IL1B+_Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.32e-04 | 196 | 59 | 4 | 7bc0735d324ac5a1661434cda4116ddd58296730 | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-04 | 197 | 59 | 4 | 2662138671262b30508c5759038bcdcfe6551696 | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgG_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.34e-04 | 197 | 59 | 4 | 6b0941883e40bd82c65659b97a4752e8e32ac190 | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-04 | 197 | 59 | 4 | 0e56255862fed099e771ebd2529393dc5a3641ba | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_cell-B_mature|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-04 | 197 | 59 | 4 | da175e66d0a743a1b91d46f224b5ff1d37aa5410 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-myeloid_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.34e-04 | 197 | 59 | 4 | 9838dbd1623babf8de7e9126a28fe5d3666bce42 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_cell-B_naive|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-04 | 198 | 59 | 4 | 79c690d21d3420d0bb1a3b3b4ea2c9aa3810a219 | |
| ToppCell | IPF-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class | 1.40e-04 | 199 | 59 | 4 | 3c2b362d5e824e1a04830e70352f8818de984174 | |
| ToppCell | mild_COVID-19_(asymptomatic)-Classical_Monocyte|World / disease group, cell group and cell class (v2) | 1.40e-04 | 199 | 59 | 4 | 727122b6f4ca265d2826c9271b10a4215a9d45a3 | |
| ToppCell | (1)_T_cell-(16)_Tfh|(1)_T_cell / shred on Cell_type and subtype | 1.42e-04 | 200 | 59 | 4 | 3b28137e8e69b98fde9f6ab8320cb4d1c3543ef9 | |
| Computational | Genes in the cancer module 58. | 3.07e-05 | 21 | 32 | 3 | MODULE_58 | |
| Computational | Complement. | 4.08e-05 | 23 | 32 | 3 | MODULE_130 | |
| Drug | 3-Amino-5-Phenylpentane | 6.38e-06 | 2 | 58 | 2 | DB02869 | |
| Drug | AC1L9IGO | 7.33e-06 | 184 | 58 | 6 | CID000445722 | |
| Drug | Etodolac [41340-25-4]; Up 200; 14uM; PC3; HT_HG-U133A | 1.08e-05 | 197 | 58 | 6 | 2091_UP | |
| Disease | Complement deficiency disease | 4.57e-07 | 33 | 56 | 4 | C0272242 | |
| Disease | C3 glomerulopathy | 5.39e-07 | 9 | 56 | 3 | C4087273 | |
| Disease | hemopexin measurement | 1.06e-06 | 11 | 56 | 3 | EFO_0008149 | |
| Disease | complement factor H-related protein 5 measurement | 1.23e-06 | 42 | 56 | 4 | EFO_0008098 | |
| Disease | complement factor H-related protein 4 measurement | 2.31e-06 | 49 | 56 | 4 | EFO_0600091 | |
| Disease | zinc finger protein 329 measurement | 3.54e-06 | 2 | 56 | 2 | EFO_0803276 | |
| Disease | leucine-rich repeat-containing protein 19 measurement | 3.54e-06 | 2 | 56 | 2 | EFO_0801762 | |
| Disease | CFHR5 DEFICIENCY | 3.54e-06 | 2 | 56 | 2 | C3553720 | |
| Disease | phosphopantothenoylcysteine decarboxylase measurement | 3.54e-06 | 2 | 56 | 2 | EFO_0802867 | |
| Disease | level of otoraplin in blood serum | 3.54e-06 | 2 | 56 | 2 | OBA_2042720 | |
| Disease | protein FAM209B measurement | 3.54e-06 | 2 | 56 | 2 | EFO_0802943 | |
| Disease | complement factor H-related protein 1 measurement | 3.97e-06 | 56 | 56 | 4 | EFO_0600054 | |
| Disease | level of alpha-N-acetylglucosaminidase in blood serum | 1.06e-05 | 3 | 56 | 2 | OBA_2042500 | |
| Disease | soluble transferrin receptor measurement | 1.06e-05 | 3 | 56 | 2 | EFO_0004460 | |
| Disease | calnexin measurement | 1.06e-05 | 3 | 56 | 2 | EFO_0801444 | |
| Disease | histone-lysine N-methyltransferase 2D measurement | 1.06e-05 | 3 | 56 | 2 | EFO_0801683 | |
| Disease | complement factor H-related protein 4A measurement | 1.06e-05 | 3 | 56 | 2 | EFO_0600057 | |
| Disease | NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial measurement | 2.12e-05 | 4 | 56 | 2 | EFO_0803292 | |
| Disease | kallikrein-5 measurement | 2.12e-05 | 4 | 56 | 2 | EFO_0020515 | |
| Disease | complement factor H-related protein 2 measurement | 2.28e-05 | 29 | 56 | 3 | EFO_0600055 | |
| Disease | Age related macular degeneration | 2.53e-05 | 30 | 56 | 3 | C0242383 | |
| Disease | complement C1s subcomponent measurement | 5.28e-05 | 6 | 56 | 2 | EFO_0008091 | |
| Disease | complement factor H measurement | 6.56e-05 | 41 | 56 | 3 | EFO_0008097 | |
| Disease | DNA repair protein XRCC4 measurement | 9.83e-05 | 8 | 56 | 2 | EFO_0801532 | |
| Disease | Hemolytic-uremic syndrome | 1.26e-04 | 9 | 56 | 2 | cv:C0019061 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily A member 5 measurement | 1.26e-04 | 9 | 56 | 2 | EFO_0801766 | |
| Disease | Atypical hemolytic-uremic syndrome | 1.26e-04 | 9 | 56 | 2 | cv:C2931788 | |
| Disease | atrophic macular degeneration, age-related macular degeneration, wet macular degeneration | 2.05e-04 | 60 | 56 | 3 | EFO_0001365, EFO_0004683, EFO_1001492 | |
| Disease | complement factor H-related protein 3 measurement | 3.02e-04 | 169 | 56 | 4 | EFO_0600056 | |
| Disease | otitis media (biomarker_via_orthology) | 4.72e-04 | 17 | 56 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | age-related macular degeneration | 6.55e-04 | 89 | 56 | 3 | EFO_0001365 | |
| Disease | coagulation factor measurement | 6.58e-04 | 20 | 56 | 2 | EFO_0004634 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FQFYSKGVYYDESCN | 256 | P43235 | |
| NFYAYGFSVTYSCDP | 191 | P04003 | |
| SFQFYKSGIYFEPDC | 256 | O60911 | |
| CNSPYIVGFYGAFYS | 121 | Q02750 | |
| TAVKRYYTFNTYPGC | 336 | Q2M385 | |
| YYTFNTYPGCTDLNS | 341 | Q2M385 | |
| NKSISYYGCALQFYF | 91 | Q13606 | |
| NYYSSCFYIAFFKGK | 561 | Q4KMQ2 | |
| YDFGDAQKTASYYSP | 211 | Q8WWA0 | |
| DPSTGCYMYYFQYLS | 306 | Q9NQR1 | |
| PEDFAVYYCQQYGSS | 101 | A0A0C4DH25 | |
| YPGRFDYVFYVSCKE | 196 | Q86W26 | |
| YSAKFASCFYGPFRD | 196 | P13716 | |
| GNIFLTSYQYPFYDC | 601 | O15031 | |
| DGFAAYPCTSYKSFE | 296 | P54315 | |
| TFDGLYYSYQGNCTY | 4491 | Q02817 | |
| PTGEVFYYSCEYNFV | 46 | P36980 | |
| FYYSCEYNFVSPSKS | 51 | P36980 | |
| YNDSFKYTLYGCMFS | 11 | P43657 | |
| SYHYPSCDLYFVGAS | 141 | Q9BSC4 | |
| KYCFPYFGCRFSSIY | 76 | P0DTF9 | |
| TQGFFCYDSTYAKPY | 46 | Q96GM1 | |
| GASFAGFYYICFQKS | 251 | Q8IVV7 | |
| FQTAACFHYPKYFQS | 256 | Q3MJ16 | |
| AMFESLFSYYNQYCP | 156 | Q96A11 | |
| SSSYYIAGYTPYAEC | 801 | Q9Y2L6 | |
| FYNDTVTFKCYSGFT | 621 | P20023 | |
| SEAQCKPYYSDYSRF | 1586 | O43497 | |
| SPANNICFYGECSYY | 356 | Q8IXL6 | |
| SYGCYFVPAFSGLYA | 361 | P32189 | |
| SYSYYCDQNFVTPSG | 51 | Q92496 | |
| FPVATGQSYSYYCDQ | 291 | Q92496 | |
| PTGEVFYYSCEYNFV | 46 | Q9BXR6 | |
| FYYSCEYNFVSPSKS | 51 | Q9BXR6 | |
| FPFTYKGSVYFTCTH | 31 | Q96BH3 | |
| PEDFAVYYCQQYGSS | 101 | P01619 | |
| FYGFPDCYNYDFLSP | 201 | Q12794 | |
| PTGEVFYYSCEYNFV | 46 | Q03591 | |
| FYYSCEYNFVSPSKS | 51 | Q03591 | |
| ICAFPGIYYFSYDIT | 186 | Q9BXJ2 | |
| FGSSCFEYQKLYTYI | 356 | O43781 | |
| FETFDGIYYYFPGNC | 131 | Q3ZCN5 | |
| STNCPYYNEYFVFDF | 291 | Q9HC10 | |
| SAYASSYYRAGSKPF | 591 | Q9H4L5 | |
| SYTDFPCQYVKDTYA | 171 | Q86XI6 | |
| YFVGGQSYNCPYSTT | 11 | A6NCL1 | |
| LDTSGTYPFCTYYFV | 326 | Q6XZB0 | |
| YTDPLKFYATSYCTA | 21 | Q7Z5V6 | |
| PSTNLYFADFYCMYT | 216 | Q92561 | |
| SQCDSPYITRYFGSY | 71 | O00506 | |
| FGYQDCVTYYKAASP | 296 | Q96SE0 | |
| SVFCGVYEQPYYYSD | 251 | P35523 | |
| PYTNYTFDFKGVIDY | 476 | Q96LI5 | |
| QCDSPYVVKYYGSYF | 76 | Q13188 | |
| YTCEFCGKQYKYYTP | 256 | Q5T7W0 | |
| AEFYGSKEDPQTFYY | 101 | P02787 | |
| GFTRLSSSPCYYFYQ | 496 | Q8N5U6 | |
| SSSPCYYFYQAEDGQ | 501 | Q8N5U6 | |
| SKDSPYYQGFESYYS | 886 | O15014 | |
| GTFNYSPDVYCSKYN | 71 | Q9H9P5 | |
| YCCSESSFFAKIPYY | 771 | Q13342 | |
| EYGNTCSFYKDFNVY | 231 | Q6P280 | |
| ALAYFPYFITYKCSG | 11 | Q9BVK8 | |
| TFNYSPDVYCTKYDE | 81 | Q9C0B0 | |
| AGNYSCMYYQTKSPF | 191 | B6A8C7 | |
| GYKFYVCNEYGTTFS | 261 | Q8WTR7 |